Capital dedicated by local investors to risky investments that was once largely tied up in junior explorers is starting to flow to early-stage biotech companies,…

ASX listed biotech company Prescient Therapeutics (ASX: PTX) has this week unveiled two significant licence agreements that forms the IP backbone of its work into…

OmniCAR could answer many questions for first-gen CAR-T approaches. Last night, Australian based Prescient hosted an investor call, and announced a licensing agreement with U….

Biotech company Prescient Therapeutics (ASX: PTX) emerged from a trading halt this morning to unveil two significant licences related to its universal immune receptor technology platform, currently…

Anti-cancer biotech company Prescient Therapeutics (PTX) has received two key licences to build a new cell therapy platform. Prescient revealed today it has received an…

It is impossible to overstate the unprecedented disruptions the world is facing with COVID-19. Stock markets have plunged worldwide and our healthcare system is overworked….

AFL player Ben Brown recently shared a story about his cousin Grace’s battle with cancer, imploring people to stay home during the pandemic to protect…

Cancer is the leading cause of death in Australia, claiming almost 50,000 lives in 2019. The most common treatments for cancer include chemo and radiation…

When you think of cancer therapies, you may automatically think of chemo and radiation. While those are highly effective at putting certain cancers into remission,…

Personalised medicine seems to be the way of the future; where patients receive tailored treatments to suit their individual needs and biometric traits. Medicine and…